NCT00093379: Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer |
|
|
| Completed | 2 | 20 | US | Capecitabine, Xeloda, Oxaliplatin, Eloxatin, Radiation Therapy (XRT), XRT, RT, Radiotherapy | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Anal Cancer | 07/12 | 07/12 | | |
